Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Neurology & CNS · Approved programs

Neurology & CNS programs at Approved programs — ClinicalTrials.gov pipeline intelligence.

Programs 64

Quick answer

Neurology & CNS Approved programs programs: NovaPharmaNews indexes 64 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Pipeline programs

Page 1 of 2

  1. 202000842

    Disc Medicine

    Depression

    approved small molecule active

    1 trial

  2. AGEE cream

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule terminated

    1 trial

  3. APOKYN

    SUPERNUS PHARMACEUTICALS, INC.

    Parkinson's Disease

    approved small molecule terminated

    2 trials

  4. Alcohol Wipes vs. No Alcohol Wipes

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

  5. Antiepileptic drug therapy

    United Therapeutics Europe Ltd

    Epilepsy

    approved small molecule active

    1 trial

  6. Aripiprazole

    Otsuka Beijing Research Institute

    Schizophrenia

    approved small molecule completed

    3 trials

  7. Brand lamotrigine

    BRIGHT MINDS BIOSCIENCES INC.

    Epilepsy

    approved small molecule completed

    1 trial

  8. Butylphthalide

    The First People's Hospital of Lianyungang

    Focal Epilepsy

    approved small molecule active

    1 trial

  9. CELC200A2406

    Novartis Pharmaceuticals

    Parkinson's Disease

    approved small molecule completed

    1 trial

  10. CREXONT ER

    Amneal Pharma Europe Ltd

    Parkinson Disease

    approved small molecule active

    2 trials

  11. Cannabidiol Oral Solution [Epidiolex]

    Jazz Pharmaceuticals Ireland Limited

    Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

    approved small molecule completed

    1 trial

  12. Clozapine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  13. Copaxone

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    2 trials

  14. DONEPEZIL, DONEPEZIL

    Pari Pharma GmbH

    Interest of adding donepezil to the non-medicinal care pathway recommended in France for Alzheimer's disease

    approved small molecule active

    1 trial

  15. DR240305

    Tour Hekla

    Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by disabling symptoms of inattention and/or hyperactivity-impulsivity beginning before the age of 12 with significant personal, social, academic and/or occupational impact (American Psychiatric Association 2013). This disorder, whose prevalence is around 5% in children and adolescents, affects 2.6% of adults (American Psychiatric Association 2013; Song et al. 2021).

    approved small molecule active

    1 trial

  16. Desvenlafaxine Succinate

    Grace Therapeutics

    Vascular Depression

    approved small molecule active

    1 trial

  17. Dexmedetomidine

    BioXcel Therapeutics

    Schizophrenia Agitation

    approved small molecule active

    1 trial

  18. Dexmedetomidine Injectable Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    approved small molecule completed

    1 trial

  19. Dimethyl fumarate

    Biogen

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  20. Esketamine

    The First People's Hospital of Lianyungang

    Postpartum Depression

    approved small molecule active

    1 trial

  21. Folic Acid

    Cardiff Oncology

    Depression

    approved small molecule completed

    1 trial

  22. Glatiramer Acetate

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    approved small molecule terminated

    5 trials

  23. INTENSIFY SZ

    Disc Medicine

    schizophrenia, schizoaffective disorder, schizophrenifom disorder

    approved small molecule active

    1 trial

  24. Iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Schizophrenia

    approved small molecule active

    5 trials

  25. Kesimpta 20 mg solution for injection in pre-filled syringe

    Novartis Pharmaceuticals

    Relapsing forms of Multiple Sclerosis (RMS)

    approved small molecule active

    1 trial

  26. Ketamine

    Teva Pharma GmbH

    Treatment Resistant Depression

    approved small molecule active

    1 trial

  27. Lecanemab 10 mg/kg

    The First People's Hospital of Lianyungang

    Alzheimer s Disease

    approved small molecule active

    1 trial

  28. Lubiprostone

    Takeda

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  29. MIYAIRI 588

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression Mild

    approved small molecule completed

    1 trial

  30. Minocycline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  31. Ocrevus 300 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) [in line with the locally approved indications]

    approved small molecule active

    1 trial

  32. Ofatumumab

    Novartis Pharmaceuticals

    Relapsing Multiple Sclerosis

    approved mab completed

    1 trial

  33. Oral Zonisamide Therapy

    Affiliated Hospital of Nantong University

    Epilepsies, Partial

    approved small molecule active

    1 trial

  34. PERSERIS

    Indivior Pty Ltd

    Schizophrenia

    approved small molecule completed

    1 trial

  35. Paliperidone ER

    Hospital Authority, Hong Kong

    Schizophrenia

    approved small molecule completed

    1 trial

  36. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Parkinson Disease Psychosis

    approved small molecule completed

    1 trial

  37. ROP

    GlaxoSmithKline

    Parkinson Disease

    approved small molecule completed

    1 trial

  38. Ramelteon

    Takeda

    Schizophrenia

    approved small molecule completed

    1 trial

  39. Rasagiline

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule active

    5 trials

  40. Rasagiline Mesylate

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    8 trials

  41. Rasagiline/Placebo

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    1 trial

  42. Rivastigmine

    Atrium Therapeutics

    Parkinson's Disease

    approved small molecule terminated

    1 trial

  43. Rivastigmine

    Novartis Pharmaceuticals

    Alzheimer's Disease

    approved small molecule completed

    1 trial

  44. Rivastigmine transdermal patch

    Novartis Pharmaceuticals

    Alzheimer's Disease

    approved small molecule completed

    1 trial

  45. SIPO20

    Verona Pharma Ireland Limited

    Active progressive multiple sclerosis course after an initial relapse clinical course

    approved small molecule active

    1 trial

  46. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis

    approved small molecule completed

    2 trials

  47. Selective serotonin reuptake inhibitor (SSRI)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anxiety Depression

    approved small molecule active

    1 trial

  48. Shared Solutions® plus MS Center v. Shared Solutions®

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

Frequently asked questions

How many neurology & cns Approved programs programs exist?

64 programs match both the therapeutic area and stage filters in our published index.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.